Table 4.
Multivariate Cox regression of G-cross AUC scores and clinical factors with overall survival
| Characteristic | HR | 95% CI | P value |
|---|---|---|---|
| Age | 1.04 | 1.01–1.06 | 0.002 |
| Number of positive lymph nodes | 1.18 | 1.08–1.29 | 0.0002 |
| Tumor: CD8 (G-cross) | 0.96 | 0.87–1.06 | 0.42 |
| Tumor: CD68 (G-cross) | 0.91 | 0.78–1.06 | 0.24 |
| Tumor: CD4 (G-cross) | 0.96 | 0.83–1.12 | 0.60 |
| Tumor: FoxP3 (G-cross) | 1.52 | 1.11–2.07 | 0.009 |
| CD8: FoxP3 (G-cross) | 0.96 | 0.92–0.99 | 0.042 |
| Tumor: CD8+CD68 (G-cross) | 0.95 | 0.88–1.03 | 0.23 |
| Tumor: CD8+CD4 (G-cross) | 0.97 | 0.89–1.05 | 0.40 |
| Tumor: CD8+FoxP3 (G-cross) | 0.99 | 0.90–1.08 | 0.77 |
| Tumor: CD4+CD68 (G-cross) | 0.95 | 0.86–1.05 | 0.33 |
| Tumor: FoxP3+CD68 (G-cross) | 0.98 | 0.86–1.11 | 0.71 |
| Tumor: FoxP3+CD4 (G-cross) | 0.99 | 0.90–1.15 | 0.81 |
Boldface type indicates statistical significance on multivariate analysis.
Abbreviations: AUC = area under the curve, HR = hazard ratio, CI = confidence interval.